{"id":"NCT03439254","sponsor":"Intercept Pharmaceuticals","briefTitle":"Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis","officialTitle":"A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-08-30","primaryCompletion":"2022-09-08","completion":"2022-09-08","firstPosted":"2018-02-20","resultsPosted":"2023-10-23","lastUpdate":"2023-10-23"},"enrollment":919,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Compensated Cirrhosis","Nonalcoholic Steatohepatitis"],"interventions":[{"type":"DRUG","name":"Obeticholic acid (10 mg)","otherNames":["OCA","6alpha-ethylchenodeoxycholic acid (6-ECDCA)","INT-747"]},{"type":"DRUG","name":"Obeticholic acid (10 mg to 25 mg)","otherNames":["OCA","6alpha-ethylchenodeoxycholic acid (6-ECDCA)","INT-747"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Obeticholic Acid (OCA) 10 mg","type":"EXPERIMENTAL"},{"label":"Obeticholic Acid (OCA) 10 mg to 25 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study is to evaluate whether obeticholic acid (OCA; INT-747) can lead to histological improvement in fibrosis with no worsening of NASH in adults with compensated cirrhosis due to NASH.","primaryOutcome":{"measure":"DB Phase: Number of Participants Who Were Responders and Showed Improvement in Fibrosis by at Least 1 Stage Without Worsening of Nonalcoholic Steatohepatitis (NASH)","timeFrame":"Up to 18 months","effectByArm":[{"arm":"DB: Placebo","deltaMin":31,"sd":null},{"arm":"DB: OCA 10 Milligrams (mg)","deltaMin":33,"sd":null},{"arm":"DB: OCA 10 mg Titrated to OCA 25 mg","deltaMin":37,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.6172"},{"comp":"OG000 vs OG002","p":"0.4184"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":192,"countries":["United States","Australia","Canada","France","Germany","Hungary","New Zealand","Poland","Puerto Rico","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":43,"n":312},"commonTop":["Pruritus","Nausea","Urinary tract infection","Fatigue","Arthralgia"]}}